“showed a trend”

13.5% in Q1, p < 0.001), and alcohol consumption patterns showed a trend towards higher consumption in the lower LDL/HDL ratio groups ( p = 0.032).

Higher APACHE II score showed a trend toward increased mortality, while vasopressor use within the first 24 h was associated with increased mortality risk (HR 0.47; 95% CI 0.24–0.94; p = 0.033).

Conversely, in the thalamus, while preclinical scrapie-affected animals showed a trend towards upregulation of SPP1 , a significant upregulation ( p -value = 0.033) was evident in the clinical stage of the disease, compared to healthy controls.

Serum albumin showed a trend toward a protective effect (HR = 0.82, 95% CI: 0.68–0.98, p = 0.033).

The median OS (14.17 months) was significantly superior to that of the Control group (8.88 months, P < 0.001) and showed a trend towards prolongation compared to the IP-Cis group (11.23 months, P = 0.033).

In the subgroup study, we demonstrated that compared with RASi, the use of ARNI showed a trend toward reducing the incidence of cardiovascular events, with a statistically significant difference between the two groups (HR 2.811, 95%CI 1.063 − 7.434, p = 0.033), which was consistent with previous research findings.

However, the Mann–Whitney U test comparing the biceps brachii group and the brachialis plus brachioradialis group on pronator teres toxin dose showed a trend towards significance ( p = 0.033, adjusted alpha = 0.0167), suggesting that patients in the biceps brachii group tended to receive a higher dose of pronator teres toxin.

Concerning the type of infection, patients showed a trend towards a higher rate of nosocomial infections when sTREM-1 plasma concentrations at V1 were above 532 pg/mL ( p = 0.033), whereas there was no statistical difference when the cut-off of 400 pg/mL was used ( p = 0.154).

For searching fixations, however, context showed a trend indicating an effect on duration, F (1, 16) = 5.46, p = 0.033, η G 2 = 0.13, and there was a significant effect of epoch, F (2.69, 43.02) = 5.73, ε GG = 0.896, p = 0.003, η G 2 = 0.022, but no interaction, F (1.91, 30.58) = 5.73, ε GG = 0.896, p = 0.307.

Participants with hypoxic burden ≥42%min·h −1 showed a trend towards higher likelihood of significant decline in phonemic fluency (OR 2.26, p=0.033, according to Model 3) ( supplementary tables S10 and S11 ).

The DMN and VAN also showed a trend of increased IntraNC (DMN: p = .033; VAN: p = .011), but these results failed to reach significance once corrected for multiple comparisons.

Overall survival showed a trend toward worse prognosis in patients with germline mutations ( P =0.034); however, this difference did not reach statistical significance in multivariate analysis that included age, 2022 ELN risk classification, and allogeneic HCT status (hazard ratio =1.00; 95% confidence interval: 0.53-1.86; P =0.989) ( Online Supplementary Figure S2 ).

While transfection with Snail-1 specific siRNA showed a trend toward downregulating vimentin expression in HEC-1A cells following treatment with 60 pmol/mL, this effect did reach statistical significance ( P = 0.034) ( Figure 6b ).

Patients operated at high-volume center were more likely to have received neoadjuvant chemotherapy (21.6% versus 8.9%, p = 0.015) and showed a trend for having undergone more frequently RAMPS (51.0% versus 36.0%, p = 0.034).

The altered group again showed a trend toward reduced DFS, although the median survival could not be calculated due to limited events (p = 0.0345, q = 0.0345).

DRGs treated with human bevacizumab + FUS (nDRGs = 12; voxel: 98.2 ± 43.7; diameter: 0.86 ± 0.14 mm) showed a trend to being smaller ( p = 0.035) than those receiving human bevacizumab alone (nDRGs = 24; voxel: 144.8 ± 72.1; diameter: 1.02 ± 0.17 mm).

The comparison between II1 and II2 showed a trend towards significance (raw p = 0.035), but this difference did not remain significant after Holm adjustment (p adj = 0.070).

However, Weighted Unifrac distance (panel C) showed a trend toward distinct clusters between HC and TSD (raw p -value = 0.035, adj p -value = 0.105) and to a lesser extent between HC and EPI (raw p -value = 0.074, adj p -value = 0.111).

Rs2241409 showed a trend towards association with grade ≥3 HFS ( p = 0.035), however, this association is not statistically significant at the threshold set in the study ( Rosmarin et al., 2014 ).

The results showed a trend towards a smaller total indirect effect on cognition (coefficient = 0.022 (0.01), p = 0.035) through the vascular risk score, which subsequently influenced WM outcomes (Genu-FA), microbleed occurrence, and, to a lesser extent, tau deposition.

Preliminary results showed a trend towards improved DSF in patients showing ctDNA clearance (HR 0.25; 95% CI: 0.06–1.01 p = 0.035).

In contrast, the variance of max opening velocity showed a trend toward being smaller on the deviated side ( p = 0.035), but this difference did not remain significant after FDR correction (q = 0.070).

Dunn’s post hoc test revealed that the Shannon diversity was significantly higher, and Chao1 species richness indices showed a trend toward higher in PN samples than in PD samples (adjusted p = 0.0358 and 0.0598, respectively).

Atp1a3 +/D801Y males showed a trend to lower weights only above 4 months of age; linear regression analysis found a significant difference ( p = 0.036; Fig. 1 B ).

Within the opioid-FM group, higher pain sensitivity to heat (i.e., lower sensitivity-adjusted temperatures) showed a trend relationship with higher opioid dosage ( r = −0.45, p = 0.036), potentially reflective of opioid-related hyperalgesia.